Executive Change · Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): May 7, 2025     National Research Corporation (Exact name of registrant as specified in its charter)   Delaware 001-35929 47-0634000 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   1245 Q Street , Lincoln , Nebraska 68508 (Address of principal executive offices) (Zip Code)   ( 402 ) 475-2525 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered $0.001 Par Value Common Stock NRC The NASDAQ Stock Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐         Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On May 7, 2025, the shareholders of National Research Corporation, a Delaware corporation (the “Company”), approved the National Research Corporation 2025 Omnibus Incentive Plan (the “2025 Omnibus Incentive Plan”). The 2025 Omnibus Incentive Plan became effective on May 7, 2025, and replaces the National Research Corporation 2006 Equity Incentive Plan and the National Research Corporation 2004 Non-Employee Director Stock Plan, as amended.    The terms of the 2025 Omnibus Incentive Plan are described in the Company’s proxy statement for the 2025 Annual Meeting of Shareholders (the “Annual Meeting”) filed with the Securities and Exchange Commission on April 10, 2025 (the “Proxy Statement”) in the section thereof titled “Proposal 4 – Approval of the National Research Corporation 2025 Omnibus Incentive Plan.” The text of the 2025 Omnibus Incentive Plan is set forth as Appendix A to the Proxy Statement.   Item 5.07 Submission of Matters to a Vote of Security Holders.   The Annual Meeting was held on May 7, 2025. Four proposals were voted on at the Annual Meeting. The proposals are described in detail in the Proxy Statement. The final results for the votes regarding each proposal are set forth below.   1. Donald M. Berwick and Stephen H. Lockhart were elected to serve as directors for three-year terms to expire at the Company’s 2028 annual meeting of shareholders:   Name   For   Against   Abstain   Broker Non-Votes Donald M. Berwick   20,930,792   103,066   22,243   829,100 Stephen H. Lockhart   20,950,429   80,649   25,023   829,100   2. The appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2025 was ratified:   For   Against   Abstain   Broker Non-Votes 21,710,551   172,003   2,647   —   3. The compensation of the Company’s named executive officers as described in the Proxy Statement was approved on an advisory and non-binding basis:   For   Against   Abstain   Broker Non-Votes 20,655,974   217,494   182,633   829,100   4. The 2025 Omnibus Incentive Plan was approved:   For   Against   Abstain   Broker Non-Votes 16,852,672   4,017,318   186,111   829,100         SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     NATIONAL RESEARCH CORPORATION   (Registrant)         Date: May 12, 2025 By: /s/ Michael D. Hays     Michael D. Hays     Chief Executive Officer